Clinical trial
Optimal Medical Treatment of Difficult-to-treat Hypertension
NCT06275763 is registered in ClinicalTrials.gov with National Institute of Cardiology, Warsaw, Poland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Medical Treatment of Difficult-to-treat Hypertension
- Lead sponsor
- National Institute of Cardiology, Warsaw, Poland
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 20, 2023
- Completion date
- December 31, 2025
- Enrollment
- 2,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.